Animal models reveal pathophysiologies of tyrosinemiasENDO, Fumio; TANAKA, Yasuhiko; TOMOEDA, Kaede et al.The Journal of nutrition. 2003, Vol 133, Num 6, pp 2063-2067, issn 0022-3166, 5 p., SUP1Conference Paper

Presentation of the data of the italian registry for oculocutaneous tyrosinaemiaFOIS, A; BORGOGNI, P; ROMANO, C et al.Journal of inherited metabolic disease. 1986, Vol 9, pp 262-264, issn 0141-8955, suppl. 2Conference Paper

Treatment of hereditary tyrosinaemia (fumarylacetoacetase deficiency) by enzyme substitutionLINDBLAD, B; FRIDEN, J; GRETER, J et al.Journal of inherited metabolic disease. 1986, Vol 9, pp 257-261, issn 0141-8955, suppl. 2Conference Paper

Successfull dietary control of tyrosinemia IIMACHINO, H; MIKI, Y; KAWATSU, T et al.Journal of the American Academy of Dermatology. 1983, Vol 9, Num 4, pp 533-539, issn 0190-9622Article

Neurologic crises in hereditary tyrosinemiaMITCHELL, G; LAROCHELLE, J; KHAZAL PARADIS et al.The New England journal of medicine. 1990, Vol 322, Num 7, pp 432-437, issn 0028-4793Article

Le traitement diététique de la tyrosinémie héréditaire: à propos de sept cas = Dietary management of hereditary tyrosinemiaJEHAN, P; BUCHMAN, M; ODIEVRE, M et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 20, pp 1412-1417, issn 0037-1777Article

Persistent Tyrosinemia associated with low activity of tyrosine aminotransferaseANDERSSON, S; NEMETH, A; OHISALO, J et al.Pediatric research. 1984, Vol 18, Num 7, pp 675-678, issn 0031-3998Article

Tyrosinemia and intractable seizuresSESHIA, S. S; PERRY, T. L; DAKSHINAMURTI, K et al.Epilepsia (Copenhagen). 1984, Vol 25, Num 4, pp 457-463, issn 0013-9580Article

Hereditary tyrosinemia: formation of succinylacetone ― Amino acid adductsMANABE, S; SASSA, S; KAPPAS, A et al.The Journal of experimental medicine. 1985, Vol 162, Num 3, pp 1060-1074, issn 0022-1007Article

TYROSINOSIS. = TYROSINOSEBAKKER HD; VAN SPRANG FJ.1976; NEDERL. T. GENEESKDE; NEDERL.; DA. 1976; VOL. 120; NO 22; PP. 944-951; ABS. ANGL.; BIBL. 1 P.Article

A propos de deux cas de tyrosinose de type II (syndrome de Richner-Hanhart) = About two cases of tyrosinosis II (Richner-Hanhart syndrome)ROUSSAT, B; FOURNIER, F; BESSON, D et al.Bulletin des sociétés d'ophtalmologie de France. 1988, Vol 88, Num 6-7, pp 751-757, issn 0081-1270Article

Tyrosinemia type I : Diagnostic issues and prenatal diagnosisBIJARNIA, Sunita; PURI, Ratna D; RUEL, Jean et al.Indian journal of pediatrics. 2006, Vol 73, Num 2, pp 163-165, issn 0019-5456, 3 p.Article

Determination of urinary succinylacetone by capillary gas chromatographyTUCHMAN, M; WHITLEY, C. B; RAMNARAINE, M. L et al.Journal of chromatographic science. 1984, Vol 22, Num 5, pp 211-215, issn 0021-9665Article

HEREDITARY TYROSINEMIA AND THE HEME BIOSYNTHETIC PATHWAY: PROFOUND INHIBITION OF DELTA -AMINOLEVULINIC ACID DEHYDRATASE ACTIVITY BY SUCRINYLACETONESASSA S; KAPPAS A.1983; JOURNAL OF CLINICAL INVESTIGATION; ISSN 0021-9738; USA; DA. 1983; VOL. 71; NO 3; PP. 625-634; BIBL. 41 REF.Article

Increased nitric oxide release by neutrophils of a patient with tyrosinemia type IIID'EUFEMIA, Patrizia; FINOCCHIARO, Roberto; CELLI, Mauro et al.Biomedicine & pharmacotherapy. 2009, Vol 63, Num 5, pp 359-361, issn 0753-3322, 3 p.Article

Clinical practice: NTBC therapy for tyrosinemia type 1: how much is enough?EL-KARAKSY, Hanaa; RASHED, Mohmmad; EL-SAYED, Rokaya et al.European journal of pediatrics. 2010, Vol 169, Num 6, pp 689-693, issn 0340-6199, 5 p.Article

A GC/MS validated method for the nanomolar range determination of succinylacetone in amniotic fluid and plasma : An analytical tool for tyrosinemia type ICYR, Denis; GIGUERE, Robert; VILLAIN, Gaëlle et al.Journal of chromatography. B. 2006, Vol 832, Num 1, pp 24-29, issn 1570-0232, 6 p.Article

Stability of 5-aminolevulinic acid on dried urine filter paper for a diagnostic marker of tyrosinemia type ISHINKA, Toshihiro; OHSE, Morimasa; INOUE, Yoshito et al.Journal of chromatography. B. 2005, Vol 823, Num 1, pp 44-46, issn 1570-0232, 3 p.Conference Paper

Tyrosinemia type I: A clinico-laboratory case reportKARNIK, Deepali; THOMAS, Niranjan; EAPEN, C. E et al.Indian journal of pediatrics. 2004, Vol 71, Num 10, pp 929-932, issn 0019-5456, 4 p.Article

Vier Fälle von Richner-Hanhart-Syndrom (Tyrosinämie Typ II) mit neurologischer Symptomatologie in einer jugoslawischen Familie = Quatre cas de syndrome de Richner-Hanhart (tyrosinémie de type II) avec symptomatologie neurologique dans une famille yougoslave = Four cases of Richner-Hanhart syndrome (tyrosinemia type II) with neurological synptome in a Yugoslavian familySALAMON, T; HRNJICA, M; SCHNYDER, U. W et al.Hautarzt. 1988, Vol 39, Num 3, pp 149-154, issn 0017-8470Article

Visceral pathology of hereditary tyrosinemia type IRUSSO, P; O'REGAN, S.American journal of human genetics. 1990, Vol 47, Num 2, pp 317-324, issn 0002-9297, 8 p.Article

Hereditary tyrosinemia type I: an overviewKVITTINGEN, E. A.Scandinavian journal of clinical & laboratory investigation. Supplement. 1986, Vol 46, Num 184, pp 27-34, issn 0085-591XArticle

Pseudodentritic keratitis associated with meibomitis in young healthy malesJAIN, V; SRIDHAR, M. S; VADDAVALLI, P. K et al.Eye (London. 1987). 2007, Vol 21, Num 6, pp 826-828, issn 0950-222X, 3 p.Article

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I)TANGUAY, R. M; VALET, J. P; LESCAULT, A et al.American journal of human genetics. 1990, Vol 47, Num 2, pp 308-316, issn 0002-9297, 9 p.Article

Tyrosinaemia type II (Richner―Hanhart syndrome): report of two cases treated with etretinateFRASER, N. G; MACDONALD, J; GRIFFITHS, W. A. D et al.Clinical and experimental dermatology (Print). 1987, Vol 12, Num 6, pp 440-443, issn 0307-6938Article